FR2373795A1 - Dosage immunologique par enzyme fixee - Google Patents

Dosage immunologique par enzyme fixee

Info

Publication number
FR2373795A1
FR2373795A1 FR7737194A FR7737194A FR2373795A1 FR 2373795 A1 FR2373795 A1 FR 2373795A1 FR 7737194 A FR7737194 A FR 7737194A FR 7737194 A FR7737194 A FR 7737194A FR 2373795 A1 FR2373795 A1 FR 2373795A1
Authority
FR
France
Prior art keywords
antigen
antibody
fixed enzyme
phase
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7737194A
Other languages
English (en)
French (fr)
Other versions
FR2373795B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlo Erba SpA filed Critical Carlo Erba SpA
Publication of FR2373795A1 publication Critical patent/FR2373795A1/fr
Application granted granted Critical
Publication of FR2373795B1 publication Critical patent/FR2373795B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7737194A 1976-12-10 1977-12-09 Dosage immunologique par enzyme fixee Granted FR2373795A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51709/76A GB1549069A (en) 1976-12-10 1976-12-10 Enzyme linked immunoassay

Publications (2)

Publication Number Publication Date
FR2373795A1 true FR2373795A1 (fr) 1978-07-07
FR2373795B1 FR2373795B1 (enExample) 1982-09-10

Family

ID=10461077

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7737194A Granted FR2373795A1 (fr) 1976-12-10 1977-12-09 Dosage immunologique par enzyme fixee

Country Status (26)

Country Link
JP (1) JPS53101522A (enExample)
AR (1) AR226805A1 (enExample)
AU (1) AU517266B2 (enExample)
BE (1) BE861711A (enExample)
BR (1) BR7708181A (enExample)
CA (1) CA1110165A (enExample)
CH (1) CH628739A5 (enExample)
CS (1) CS208739B2 (enExample)
DE (1) DE2755008A1 (enExample)
DK (1) DK550077A (enExample)
ES (2) ES464929A1 (enExample)
FI (1) FI773718A7 (enExample)
FR (1) FR2373795A1 (enExample)
GB (1) GB1549069A (enExample)
GR (1) GR63580B (enExample)
HK (1) HK13881A (enExample)
HU (1) HU179956B (enExample)
IL (1) IL53576A (enExample)
IT (1) IT1109485B (enExample)
MY (1) MY8100367A (enExample)
NL (1) NL7713692A (enExample)
NO (1) NO774240L (enExample)
NZ (1) NZ185927A (enExample)
PT (1) PT67384B (enExample)
SE (1) SE7714034L (enExample)
TR (1) TR20650A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233044A3 (en) * 1986-02-03 1990-07-25 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and use of products thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS576363A (en) * 1980-06-13 1982-01-13 Takeda Chem Ind Ltd Production of specific antibody
CA1160566A (en) * 1980-04-25 1984-01-17 Harald Gallati Immunological determination method
ES8307897A1 (es) * 1981-04-13 1983-08-01 Hoechst Co American Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
JPS58501733A (ja) * 1981-07-31 1983-10-13 マウント　シナイ　スク−ル　オブ　メデイシン　オブ　ザ　シテイ　ユニバ−シテイ　オブ　ニユ−ヨ−ク ウイルス試験法
EP0072902B1 (de) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
JPS58151559A (ja) * 1982-03-05 1983-09-08 Takeda Chem Ind Ltd ヒト絨毛性ゴナドトロピンの免疫化学的測定法
US4704356A (en) * 1984-03-27 1987-11-03 Rush-Presbyterian-St. Luke's Medical Center Method of diagnosing cartilage tissue abnormalities
CH670709A5 (enExample) * 1986-04-24 1989-06-30 Univ Moskovsk
AT388618B (de) * 1987-05-05 1989-08-10 Binder Bernd Dr Verfahren zur quantitativen bestimmung von funktion und antigener konzentration einer in einer biologischen fluessigkeit enthaltenen substanz
DE3807440A1 (de) * 1988-03-07 1989-09-21 Progen Biotechnik Gmbh Verfahren zum immunologischen nachweis von substanzen sowie eine derartige zusammensetzung und ein testkit
DE19508264C1 (de) * 1995-03-08 1996-02-01 Klose Werner Dipl Ing Fh Verfahren und Vorrichtung zum Vermessen von Konturen, insbesondere des Straßenverlaufs
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2126760A5 (enExample) * 1971-02-10 1972-10-06 Organon Nv
US3839153A (en) * 1970-12-28 1974-10-01 Akzona Inc Process for the detection and determination of specific binding proteins and their corresponding bindable substances
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease
FR2314499A1 (fr) * 1975-06-10 1977-01-07 Weeke Bengt Procede pour deceler des anticorps dans des fluides corporels a l'aide d'antigene connus ou pour determiner des antigenes a l'aide d'anticorps connus provenant de fluides corporels
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839153A (en) * 1970-12-28 1974-10-01 Akzona Inc Process for the detection and determination of specific binding proteins and their corresponding bindable substances
FR2126760A5 (enExample) * 1971-02-10 1972-10-06 Organon Nv
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease
FR2314499A1 (fr) * 1975-06-10 1977-01-07 Weeke Bengt Procede pour deceler des anticorps dans des fluides corporels a l'aide d'antigene connus ou pour determiner des antigenes a l'aide d'anticorps connus provenant de fluides corporels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0233044A3 (en) * 1986-02-03 1990-07-25 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and use of products thereof
EP0596459A3 (en) * 1986-02-03 1994-06-01 Cambridge Biotech Corporation Process for purifying recombinant proteins, and use of products thereof

Also Published As

Publication number Publication date
ES464929A1 (es) 1979-01-01
BE861711A (fr) 1978-03-31
JPS53101522A (en) 1978-09-05
GR63580B (en) 1979-11-22
NZ185927A (en) 1980-02-21
PT67384A (en) 1978-01-01
GB1549069A (en) 1979-08-01
BR7708181A (pt) 1978-07-11
SE7714034L (sv) 1978-06-11
AR226805A1 (es) 1982-08-31
NO774240L (no) 1978-06-13
HU179956B (en) 1983-01-28
AU3139577A (en) 1979-06-14
DE2755008A1 (de) 1978-06-15
CH628739A5 (en) 1982-03-15
NL7713692A (nl) 1978-06-13
ES468934A1 (es) 1978-12-16
AU517266B2 (en) 1981-07-16
CS208739B2 (en) 1981-09-15
DK550077A (da) 1978-06-11
TR20650A (tr) 1982-03-24
IT1109485B (it) 1985-12-16
PT67384B (en) 1979-05-18
FR2373795B1 (enExample) 1982-09-10
CA1110165A (en) 1981-10-06
IL53576A (en) 1981-07-31
MY8100367A (en) 1981-12-31
HK13881A (en) 1981-04-16
IL53576A0 (en) 1978-03-10
FI773718A7 (fi) 1978-06-11

Similar Documents

Publication Publication Date Title
FR2373795A1 (fr) Dosage immunologique par enzyme fixee
FI903515A0 (fi) Testimenetelmä ja reagenssikitti sitä varten
FR2458072A1 (fr) Procede, equipement et composition pour l'analyse qualitative et le dosage immuno-enzymatique de substances biologiques
JPS6343711B2 (enExample)
FR2366568A1 (fr) Procede pour la determination d'une substance immunologiquement active
JPH0521187B2 (enExample)
FR2387452A1 (fr) Procede et dispositif pour la determination avec un adsorbant d'une substance a fixation specifique
ES8802256A1 (es) Un metodo cromatografico de afinidad para la determinacion de antigenos en liquidos biologicos.
FR2436396A1 (fr) Procede d'analyse pour determiner directement la concentration d'un composant libre dans un echantillon
EP0022005A1 (fr) Procédé de séparation d'une substance protéinique à partir d'une solution la contenant par filtration d'affinité et application dudit procédé aux dosages enzymatiques
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
FR2425074A1 (fr) Reactif et methode de detection de l'hepatite b
ATE177113T1 (de) Neue verbindungen und konjugate
NO163586C (no) Immunologiske jodtyroninanalyser hvor hms brukes som tbp-blokkerende middel.
JPS63142267A (ja) 試料からの分析物を測定する方法および試験担体
FR2355293A2 (fr) Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique
KR890006812A (ko) 메탐페타민에 대한 모노클로날 항체 그 모노클로날 항체의 제법 메탐페타민의 분석법 및 분석키트
Wehmeyer et al. Liquid chromatography with electrochemical detection of phenol and NADH for enzyme immunoassay
Avrameas Enzyme immunoassays and related techniques: development and limitations
FR2363793A1 (fr) Nouveau procede de dosage d'antigenes et d'anticorps, selon la technique immunologique avec enzyme fixee
US4467030A (en) Determination of the thyroxine-binding index in serum
ATE88571T1 (de) Immunologischer testkit.
ATE67603T1 (de) Zusammensetzungen zum immunoenzymatischen test von prostaglandinen.
FR2418464A1 (fr) Dosage immunochimique
Bowers et al. On-line cleavage of urinary estriol conjugates with immobilized beta-glucuronidase before liquid-chromatographic analysis.

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse